TY - JOUR AU - Zhang, B. H. AU - Yang, B. H. AU - Tang, Z. Y. PY - 2004 DA - 2004// TI - Randomized controlled trial of screening for hepatocellular carcinoma JO - J Cancer Res Clin Oncol VL - 130 UR - https://doi.org/10.1007/s00432-004-0552-0 DO - 10.1007/s00432-004-0552-0 ID - Zhang2004 ER - TY - JOUR AU - Sherman, M. PY - 2014 DA - 2014// TI - Surveillance for hepatocellular carcinoma JO - Best Pract Res Clin Gastroenterol VL - 28 UR - https://doi.org/10.1016/j.bpg.2014.08.008 DO - 10.1016/j.bpg.2014.08.008 ID - Sherman2014 ER - TY - STD TI - Hanouneh IA, Alkhouri N, Singal AG. Hepatocellular carcinoma surveillance in the 21st century: saving lives or causing harm? Clinical and molecular hepatology. 2019. https://doi.org/10.3350/cmh.2019.1001. ID - ref3 ER - TY - JOUR AU - Yu, S. J. PY - 2016 DA - 2016// TI - A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016 JO - Clinical and molecular hepatology VL - 22 UR - https://doi.org/10.3350/cmh.2016.22.1.7 DO - 10.3350/cmh.2016.22.1.7 ID - Yu2016 ER - TY - JOUR AU - Forner, A. AU - Reig, M. AU - Bruix, J. PY - 2018 DA - 2018// TI - Hepatocellular carcinoma JO - Lancet (London, England) VL - 391 UR - https://doi.org/10.1016/S0140-6736(18)30010-2 DO - 10.1016/S0140-6736(18)30010-2 ID - Forner2018 ER - TY - JOUR AU - Hasegawa, K. AU - Kokudo, N. AU - Makuuchi, M. AU - Izumi, N. AU - Ichida, T. AU - Kudo, M. AU - Ku, Y. AU - Sakamoto, M. AU - Nakashima, O. AU - Matsui, O. PY - 2013 DA - 2013// TI - Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey JO - J Hepatol VL - 58 UR - https://doi.org/10.1016/j.jhep.2012.11.009 DO - 10.1016/j.jhep.2012.11.009 ID - Hasegawa2013 ER - TY - JOUR AU - Poon, R. T. AU - Fan, S. T. AU - Lo, C. M. AU - Liu, C. L. AU - Wong, J. PY - 2002 DA - 2002// TI - Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation JO - Ann Surg VL - 235 UR - https://doi.org/10.1097/00000658-200203000-00009 DO - 10.1097/00000658-200203000-00009 ID - Poon2002 ER - TY - JOUR AU - Linn, Y. C. AU - Lau, L. C. AU - Hui, K. M. PY - 2002 DA - 2002// TI - Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts JO - Br J Haematol VL - 116 UR - https://doi.org/10.1046/j.1365-2141.2002.03247.x DO - 10.1046/j.1365-2141.2002.03247.x ID - Linn2002 ER - TY - JOUR AU - Schmidt-Wolf, I. G. AU - Negrin, R. S. AU - Kiem, H. P. AU - Blume, K. G. AU - Weissman, I. L. PY - 1991 DA - 1991// TI - Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity JO - J Exp Med VL - 174 UR - https://doi.org/10.1084/jem.174.1.139 DO - 10.1084/jem.174.1.139 ID - Schmidt-Wolf1991 ER - TY - JOUR AU - Pievani, A. AU - Borleri, G. AU - Pende, D. AU - Moretta, L. AU - Rambaldi, A. AU - Golay, J. AU - Introna, M. PY - 2011 DA - 2011// TI - Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2011-02-336321 DO - 10.1182/blood-2011-02-336321 ID - Pievani2011 ER - TY - JOUR AU - Weng, D. S. AU - Zhou, J. AU - Zhou, Q. M. AU - Zhao, M. AU - Wang, Q. J. AU - Huang, L. X. AU - Li, Y. Q. AU - Chen, S. P. AU - Wu, P. H. AU - Xia, J. C. PY - 2008 DA - 2008// TI - Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas JO - Journal of immunotherapy (Hagerstown, Md : 1997) VL - 31 UR - https://doi.org/10.1097/CJI.0b013e31815a121b DO - 10.1097/CJI.0b013e31815a121b ID - Weng2008 ER - TY - JOUR AU - Lee, J. H. AU - Lee, J. H. AU - Lim, Y. S. AU - Yeon, J. E. AU - Song, T. J. AU - Yu, S. J. AU - Gwak, G. Y. AU - Kim, K. M. AU - Kim, Y. J. AU - Lee, J. W. PY - 2015 DA - 2015// TI - Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma JO - Gastroenterology VL - 148 UR - https://doi.org/10.1053/j.gastro.2015.02.055 DO - 10.1053/j.gastro.2015.02.055 ID - Lee2015 ER - TY - JOUR AU - Hui, D. AU - Qiang, L. AU - Jian, W. AU - Ti, Z. AU - Da-Lu, K. PY - 2009 DA - 2009// TI - A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma JO - Dig Liver Dis VL - 41 UR - https://doi.org/10.1016/j.dld.2008.04.007 DO - 10.1016/j.dld.2008.04.007 ID - Hui2009 ER - TY - JOUR AU - Takayama, T. AU - Sekine, T. AU - Makuuchi, M. AU - Yamasaki, S. AU - Kosuge, T. AU - Yamamoto, J. AU - Shimada, K. AU - Sakamoto, M. AU - Hirohashi, S. AU - Ohashi, Y. PY - 2000 DA - 2000// TI - Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial JO - Lancet (London, England) VL - 356 UR - https://doi.org/10.1016/S0140-6736(00)02654-4 DO - 10.1016/S0140-6736(00)02654-4 ID - Takayama2000 ER - TY - JOUR AU - Bruix, J. AU - Sherman, M. PY - 2011 DA - 2011// TI - Management of hepatocellular carcinoma: an update JO - Hepatology (Baltimore, Md) VL - 53 UR - https://doi.org/10.1002/hep.24199 DO - 10.1002/hep.24199 ID - Bruix2011 ER - TY - JOUR AU - Austin, P. C. PY - 2011 DA - 2011// TI - An introduction to propensity score methods for reducing the effects of confounding in observational studies JO - Multivar Behav Res VL - 46 UR - https://doi.org/10.1080/00273171.2011.568786 DO - 10.1080/00273171.2011.568786 ID - Austin2011 ER - TY - JOUR AU - May, G. S. AU - DeMets, D. L. AU - Friedman, L. M. AU - Furberg, C. AU - Passamani, E. PY - 1981 DA - 1981// TI - The randomized clinical trial: bias in analysis JO - Circulation VL - 64 UR - https://doi.org/10.1161/01.CIR.64.4.669 DO - 10.1161/01.CIR.64.4.669 ID - May1981 ER - TY - JOUR AU - Marrero, J. A. AU - Kulik, L. M. AU - Sirlin, C. B. AU - Zhu, A. X. AU - Finn, R. S. AU - Abecassis, M. M. AU - Roberts, L. R. AU - Heimbach, J. K. PY - 2018 DA - 2018// TI - Diagnosis, staging, and Management of Hepatocellular Carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases JO - Hepatology (Baltimore, Md) VL - 68 UR - https://doi.org/10.1002/hep.29913 DO - 10.1002/hep.29913 ID - Marrero2018 ER - TY - JOUR PY - 2018 DA - 2018// TI - EASL clinical practice guidelines: management of hepatocellular carcinoma JO - J Hepatol VL - 69 UR - https://doi.org/10.1016/j.jhep.2018.03.019 DO - 10.1016/j.jhep.2018.03.019 ID - ref19 ER - TY - JOUR AU - Franceschetti, M. AU - Pievani, A. AU - Borleri, G. AU - Vago, L. AU - Fleischhauer, K. AU - Golay, J. AU - Introna, M. PY - 2009 DA - 2009// TI - Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes JO - Exp Hematol VL - 37 UR - https://doi.org/10.1016/j.exphem.2009.01.010 DO - 10.1016/j.exphem.2009.01.010 ID - Franceschetti2009 ER - TY - JOUR AU - Vivier, E. AU - Raulet, D. H. AU - Moretta, A. AU - Caligiuri, M. A. AU - Zitvogel, L. AU - Lanier, L. L. AU - Yokoyama, W. M. AU - Ugolini, S. PY - 2011 DA - 2011// TI - Innate or adaptive immunity? The example of natural killer cells JO - Science (New York, NY) VL - 331 UR - https://doi.org/10.1126/science.1198687 DO - 10.1126/science.1198687 ID - Vivier2011 ER - TY - JOUR AU - Beatty, G. L. AU - Gladney, W. L. PY - 2015 DA - 2015// TI - Immune escape mechanisms as a guide for cancer immunotherapy JO - Clinical cancer research : an official journal of the American Association for Cancer Research VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-1860 DO - 10.1158/1078-0432.CCR-14-1860 ID - Beatty2015 ER - TY - JOUR AU - Introna, M. AU - Borleri, G. AU - Conti, E. AU - Franceschetti, M. AU - Barbui, A. M. AU - Broady, R. AU - Dander, E. AU - Gaipa, G. AU - D'Amico, G. AU - Biagi, E. PY - 2007 DA - 2007// TI - Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study JO - Haematologica VL - 92 UR - https://doi.org/10.3324/haematol.11132 DO - 10.3324/haematol.11132 ID - Introna2007 ER - TY - JOUR AU - Schmeel, L. C. AU - Schmeel, F. C. AU - Coch, C. AU - Schmidt-Wolf, I. G. PY - 2015 DA - 2015// TI - Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC) JO - J Cancer Res Clin Oncol VL - 141 UR - https://doi.org/10.1007/s00432-014-1864-3 DO - 10.1007/s00432-014-1864-3 ID - Schmeel2015 ER - TY - JOUR AU - Hui, K. M. PY - 2012 DA - 2012// TI - CIK cells--current status, clinical perspectives and future prospects--the good news JO - Expert Opin Biol Ther VL - 12 UR - https://doi.org/10.1517/14712598.2012.676037 DO - 10.1517/14712598.2012.676037 ID - Hui2012 ER - TY - JOUR AU - Huang, Z. M. AU - Li, W. AU - Li, S. AU - Gao, F. AU - Zhou, Q. M. AU - Wu, F. M. AU - He, N. AU - Pan, C. C. AU - Xia, J. C. AU - Wu, P. H. PY - 2013 DA - 2013// TI - Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients JO - Journal of immunotherapy (Hagerstown, Md : 1997) VL - 36 ID - Huang2013 ER - TY - JOUR AU - Pan, K. AU - Li, Y. Q. AU - Wang, W. AU - Xu, L. AU - Zhang, Y. J. AU - Zheng, H. X. AU - Zhao, J. J. AU - Qiu, H. J. AU - Weng, D. S. AU - Li, J. J. PY - 2013 DA - 2013// TI - The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients JO - Ann Surg Oncol VL - 20 UR - https://doi.org/10.1245/s10434-013-3144-x DO - 10.1245/s10434-013-3144-x ID - Pan2013 ER - TY - JOUR AU - Nishimura, R. AU - Baker, J. AU - Beilhack, A. AU - Zeiser, R. AU - Olson, J. A. AU - Sega, E. I. AU - Karimi, M. AU - Negrin, R. S. PY - 2008 DA - 2008// TI - In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity JO - Blood VL - 112 UR - https://doi.org/10.1182/blood-2007-06-092817 DO - 10.1182/blood-2007-06-092817 ID - Nishimura2008 ER - TY - JOUR AU - Lu, P. H. AU - Negrin, R. S. PY - 1994 DA - 1994// TI - A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency JO - Journal of immunology (Baltimore, Md : 1950) VL - 153 ID - Lu1994 ER - TY - JOUR AU - Alvarnas, J. C. AU - Linn, Y. C. AU - Hope, E. G. AU - Negrin, R. S. PY - 2001 DA - 2001// TI - Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation JO - Biol Blood Marrow Transplant VL - 7 UR - https://doi.org/10.1053/bbmt.2001.v7.pm11349808 DO - 10.1053/bbmt.2001.v7.pm11349808 ID - Alvarnas2001 ER - TY - JOUR AU - Liao, W. J. AU - Shi, M. AU - Chen, J. Z. AU - Li, A. M. PY - 2010 DA - 2010// TI - Local recurrence of hepatocellular carcinoma after radiofrequency ablation JO - World J Gastroenterol VL - 16 UR - https://doi.org/10.3748/wjg.v16.i40.5135 DO - 10.3748/wjg.v16.i40.5135 ID - Liao2010 ER - TY - JOUR AU - Lam, V. W. AU - Ng, K. K. AU - Chok, K. S. AU - Cheung, T. T. AU - Yuen, J. AU - Tung, H. AU - Tso, W. K. AU - Fan, S. T. AU - Poon, R. T. PY - 2008 DA - 2008// TI - Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma JO - J Am Coll Surg VL - 207 UR - https://doi.org/10.1016/j.jamcollsurg.2008.01.020 DO - 10.1016/j.jamcollsurg.2008.01.020 ID - Lam2008 ER - TY - JOUR AU - Wu, J. C. AU - Huang, Y. H. AU - Chau, G. Y. AU - Su, C. W. AU - Lai, C. R. AU - Lee, P. C. AU - Huo, T. I. AU - Sheen, I. J. AU - Lee, S. D. AU - Lui, W. Y. PY - 2009 DA - 2009// TI - Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma JO - J Hepatol VL - 51 UR - https://doi.org/10.1016/j.jhep.2009.07.009 DO - 10.1016/j.jhep.2009.07.009 ID - Wu2009 ER - TY - JOUR AU - Zhong, J. H. AU - Deng, L. AU - Tan, J. T. AU - Li, L. Q. PY - 2015 DA - 2015// TI - Adjuvant immunotherapy for postoperative hepatocellular carcinoma JO - Gastroenterology VL - 149 UR - https://doi.org/10.1053/j.gastro.2015.06.056 DO - 10.1053/j.gastro.2015.06.056 ID - Zhong2015 ER -